Skip to content

To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU.

Effect of the Use of Atracurium With or Without Reversal Agent on Haemodynamic Parameters During Extubation: a Randomized Controlled Trial

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07097441
Enrollment
100
Registered
2025-07-31
Start date
2025-03-12
Completion date
2025-06-04
Last updated
2025-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Hyperventilation, Hypoxia, Residual Paralysis, Post Anesthesia, Tachycardia

Brief summary

The goal of this clinical trial is to to observe the haemodynamic parameters including Heart Rate Blood pressure Respiratory rate and Oxygen Saturation with or without giving reversal agent on extubation in patients receiving atracurium on induction , it will also observe post operative residual paralysis respiratory depression and airway reflexes in the post anaesthesia care unit Researchers will compare neostigmine which is the reversal agent and the placebo drug by giving it at the end on surgery before extubation to observe haemodynamic parameters The main questions it aims to answer are Will participants have a stable haemodymaics if no reversal ( neostigmine ) is used during extubation Will it provide a safe extubation and no complications post operatively Participants will be given Either neostigmine or placebo drug at the end of surgery before extubation Will be obseved and monitored for two hours postoperatively in the post anaesthesia care unit Will be monitored for post operative complications like respiratory depression or residual paralysis .

Detailed description

Objective : To observe the haemodynamic parameters including Heart Rate Blood pressure Respiratory rate and Oxygen Saturation with or without giving reversal agent on extubation in patients receiving atracurium on induction , and secondary objective was to observe post operative residual paralysis respiratory depression and cough and gag reflex Study design : Controlled , randomised , and triple Blind trial . Place and duration of study: Dr Ziauddin Hospital Clifton Karachi , from March to June 2025. Methodology : This was a triple blind study . A total of 100 patients were randomly assigned by the CTU to two groups , the placebo group ( Group A ) and the neoglycopyrolate group (Group B) based on computer generated allocation. At the end of the surgery, patients in Group A were administered IV normal saline and Group B were administered neoglycopyrolate 50 mcg/kg . The primary outcome was to observe heart rate , blood pressure, oxygen saturation and respiratory rate after giving the drug , before extubation , at extubation and at 1mins, 5mins, 10mins, 20mins, and 2h thereafter, while the secondary outcome was to observe post operative airway reflexes and residual paralysis in the post anaesthesia care unit

Interventions

DRUGPlacebo drug ( normal saline )

At the end of surgery patients will be given placebo ( normal saline ) instead of neostigmine ( reversal agent of atracurium ) , to observe Heart rate, blood pressure , respiratory rate and oxygen saturation on extubation and post operative airway reflexes and residual paralysis

DRUGneostigmine (reversal agent)

At the end of surgery patients will be given neostigmine ( reversal agenr ) , to observe Heart rate, blood pressure , respiratory rate and oxygen saturation on extubation and post operative airway reflexes and residual paralysis

Sponsors

Ziauddin University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
16 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* American society of anaesthesiology class 1 and 2 * Surgeries lasting for 60 mins * .Surgeries requiring general anaesthesia and tracheal intubation and single intubation dose of atracurium

Exclusion criteria

* American society of anaesthesiology class 3 and above * Any previous reaction to atracurium * Active asthma * Severe pulmonary cardiac kindney and liver disease

Design outcomes

Primary

MeasureTime frameDescription
Heart rateFrom the time of extubation till discharge from post anaesthesia care unitTo observe Heart rate, via pulse oximeter and ECG
Blood PressureFrom the time of extubation till discharge from post anaesthesia care unitto observe Blood Pressure via Sphygmomanometer
Respiratory RateFrom the time of extubation till discharge from post anaesthesia care unitto observe respiratory rate via capnometer
Oxygen SaturationFrom the time of extubation till discharge from post anaesthesia care unitto observe oxygen saturation via pulse oximeter

Secondary

MeasureTime frameDescription
Airway reflexesFrom the time of extubation till discharge from post anaesthesia care unitto observe cough and gag reflex via Binary scale e.g Yes/No
Residual paralysisFrom the time of extubation till discharge from post anaesthesia care unitto observe head lift for more than 5 secs and firm hand grip via Bonary scale e.g Yes/No

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026